Heart Of Diabetes EMPA-REG Outcome Study Meeting
Boehringer Ingelheim and Eli Lilly are excited to invite you to a meeting, which is part of our national education program, discussing the latest breakthrough with JARDIANCE® (empagliflozin) in reducing…
